LifeScan said today that it released the latest version of its OneTouch Reveal mobile app. The digital tool is designed to help people with diabetes track their blood sugar levels using their mobile devices and share data with healthcare teams and caregivers.
The newest version of LifeScan’s app includes notifications that automatically warn users of recurring high or low patterns.
People using the app can also set goals, track their blood glucose history and log information like carbohydrate intake and number of steps taken. The OneTouch Reveal app can also show users their 90-day A1c average so they can monitor their blood sugar levels over time.
The app syncs via Bluetooth with the OneTouch Verio Flex blood glucose monitoring system. LifeScan touted the app as the most downloaded diabetes app in the U.S. and Canada since 2017.
Earlier this month, Johnson & Johnson (NYSE:JNJ) closed the $2.1 billion sale of its LifeScan subsidiary to private equity player Platinum Equity.
The sale was part of the healthcare giant’s move to get out of the device segment of the diabetes business. Last year J&J announced a strategic review of the LifeScan, Animas and Calibra Medical diabetes businesses, eventually deciding shutter the Animas insulin pump unit.
